iron
Small moleculeexperimental
Direct reduced iron is an alternative iron source produced by heating an iron ore. In nature, most of the iron has an oxidized form. — NCATS
Clinical trial activity
210 trials · 281 clinical orgs · 0 marketing orgs
Phase 1
15
Phase 2
52
Phase 3
37
Phase 4
25
Earliest trial started Sep 1, 1991 (NCT01166451)
Timeline
Indications
Approved for
Studied for
- Abortion, Habitual · Phase 2/Phase 3
- Alopecia · Phase 1
- Anemia · Phase 4
- Anemia, Iron-Deficiency · Phase 4
- Aspergillosis, Allergic Bronchopulmonary · Phase 3
- Bariatric Surgery · Phase 2/Phase 3
- Carcinoma, Ovarian Epithelial · Phase 3
- Cardiovascular Diseases · Phase 1/Phase 2
- Child Development · Phase 3
- Chronic Kidney Disease-Mineral and Bone Disorder · Phase 3
- Colitis, Ulcerative · Phase 2
- Colorectal Neoplasms · Phase 4
- Communicable Diseases · Phase 3
- Crohn Disease · Phase 2
- Cyanosis · Phase 2
- Delivery, Obstetric · Phase 4
- Depression · Phase 1/Phase 2
- Diabetes Mellitus, Type 1 · Phase 2
- Diabetic Foot · Phase 2/Phase 3
- Diarrhea · Phase 4
- Fever · Phase 3
- Fibromyalgia · Phase 3
- Folic Acid Deficiency · Phase 1
- Fractures, Bone · Phase 4
- Genital Neoplasms, Female · Phase 3
- Growth · Phase 3
- Growth and Development · Phase 3
- Healthy Volunteers · Phase 3
- Heart Defects, Congenital · Phase 2
- Heart Diseases · Phase 2
- Heart Failure · Phase 4
- Heart Failure, Systolic · Phase 3
- Hematopoietic Stem Cell Transplantation · Phase 4
- Hemodynamics · Phase 1
- Hemoglobinopathies · Phase 1
- Hip Fractures · Phase 4
- Hyperphosphatemia · Phase 3
- Infant, Low Birth Weight · Phase 4
- Infant Mortality · Phase 3
- Infant Nutrition Disorders · Phase 4
- Infant, Premature, Diseases · Phase 4
- Intestinal Neoplasms · Phase 4
- Iron · Phase 4
- Iron Deficiencies · Phase 4
- Iron Overload · Phase 4
- Kidney Failure, Chronic · Phase 2
- Lymphoid Tissue · Phase 4
- Lymphoma · Phase 4
- Malaria · Phase 4
- Malnutrition · Phase 3
- Melanoma · Phase 2
- Neoplasm Metastasis · Phase 2
- Neoplasms · Phase 4
- Obstetric Labor, Premature · Phase 3
- Osteoporotic Fractures · Phase 4
- Oxidative Stress · Phase 3
- Pediatric Obesity · Phase 4
- Perinatal Death · Phase 3
- Perinatal Mortality · Phase 3
- Phenylketonurias · Phase 2
- Pneumonia · Phase 3
- Poisoning · Phase 2
- Postoperative Hemorrhage · Phase 3
- Postural Orthostatic Tachycardia Syndrome · Phase 1/Phase 2
- Pregnancy · Phase 4
- Pregnancy Complications · Phase 4
- Premature Birth · Phase 3
- Protein-Energy Malnutrition · Phase 2
- Renal Insufficiency, Chronic · Phase 4
- Sepsis · Phase 4
- Shock, Septic · Phase 4
- Thoracic Surgery · Early Phase 1
- Ulcer · Phase 2/Phase 3
- Vitamin A Deficiency · Early Phase 1
- Weight Loss · Phase 3
- Zinc · Phase 3
Mechanism of action
- IronSupplementation
iron
Chemistry & pharmacology
Loading structure…
SMILES
[Fe]- Mol. weight
- 55.845 g/mol
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaIron ↗
- NCATSE1UOL152H7 ↗
Also known as
- elemental iron
- elemental iron (as carbonyl iron)
- iron
- iron
- iron
- iron
- iron
- iron
- iron
- iron
- iron fortified rice
- sbr759
- sbr759
- sbr 759
- sbr-759
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07287371 | Phase 4 | Dec 31, 2025 | Pharmanutra s.r.l., University of Rochester |
| NCT06069856 | Phase 3 | Sep 30, 2025 | Africa Academy for Public Health, Columbia University, George Washington University, Harvard University, Ifakara Health Institute, Muhimbili University |
| NCT07156526 | N/A | Sep 10, 2025 | Qualia Life Sciences |
| NCT06942208 | N/A | Sep 1, 2025 | Mitacs, Natural Sciences and Engineering Research Council, Canada, University of Calgary |
| NCT07095244 | N/A | Sep 1, 2025 | University of British Columbia |
| NCT07084298 | Early Phase 1 (Phase 1) | Aug 31, 2025 | Natural Sciences and Engineering Research Council, Canada, University of Calgary |
| NCT06816524 | N/A | Jul 1, 2025 | Jomo Kenyatta University of Agriculture and Technology, National Institute for Public Health and the Environment, RIVM, Holland, Radboud University, Swiss Federal Institute of Technology |
| NCT06970925 | Early Phase 1 (Phase 1) | Jun 30, 2025 | Englewood Hospital and Medical Center |
| NCT06968936 | N/A | May 15, 2025 | Chongqing Medical University, Nanjing Medical University, Wenzhou Medical University, Zhejiang University |
| NCT06921343 | N/A | Apr 30, 2025 | Assuta Ashdod Hospital, Hebrew University, Meir Medical Center, Northwell Health, Technion University |
| NCT06917950 | Phase 1/Phase 2 (Phase 2) | Apr 15, 2025 | Mansoura University |
| NCT06903559 | Phase 1/Phase 2 (Phase 2) | Apr 15, 2025 | Mansoura University |
| NCT06508827 | Phase 2 | Dec 31, 2024 | Indiana University |
| NCT06670963 | Phase 4 | Nov 30, 2024 | Silesian University of Medicine |
| NCT06642337 | N/A | Nov 1, 2024 | Hawler Medical University |
| NCT06657677 | N/A | Oct 31, 2024 | Swiss Federal Institute of Technology |
| NCT06624709 | N/A | Oct 31, 2024 | University of Geneva |
| NCT06655909 | N/A | Oct 25, 2024 | Jomo Kenyatta University of Agriculture and Technology, Swiss Federal Institute of Technology |
| NCT06362837 | N/A | Sep 2, 2024 | Global Affairs Canada, McGill University, World Vision of Ireland |
| NCT06590805 | N/A | Sep 1, 2024 | Kafrelsheikh University |
Showing 20 of 210 trials
Page 1 / 11
Organizations
Research & Development (281)
281 organizations
Page 1 / 15